[1]
X. Zhou, “Baicalin ameliorates type 2 diabetes by modulating HIF-1α-mediated oxidative stress and apoptosis: A network pharmacology and experimental study”, mcb, vol. 22, no. 5, p. 1881, Apr. 2025.